Nizoral Stada Arzneimittel (Ketoconazole)

Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By blocking ergosterol production, the drug disrupts the integrity of the fungal cell membrane, leading to increased permeability, impaired growth and ultimately cell death. This mechanism targets fungi while sparing human cells that use a different sterol pathway.

The dosage and duration of Nizoral Stada Arzneimittel are determined by the prescribing clinician based on the specific condition, severity, patient age and treatment response. The product is supplied as a topical preparation, and the prescriber will provide instructions on the amount to apply, frequency and length of therapy.

Ketoconazole topical therapy should be used during pregnancy or lactation only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the need for treatment with their healthcare provider, who can weigh safety considerations and alternative options.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Nizoral Stada Arzneimittel. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Ketoconazole belongs to the azole class, which inhibits ergosterol synthesis, whereas allylamines such as terbinafine target squalene epoxidase. Azoles generally have a broader spectrum against yeasts and dermatophytes, while allylamines are often more potent against dermatophytes but less effective against Malassezia species. Choice of therapy depends on the specific organism, site of infection and patient factors.

Nizoral Stada Arzneimittel should be stored below 25 °C in its original packaging. Keep the product away from moisture, direct sunlight and extreme temperatures. Proper storage helps maintain the stability and potency of the topical formulation throughout its shelf life.

The product is applied directly to clean, dry skin in the affected area. A thin layer is spread gently and rubbed in until absorbed, usually once or twice daily as instructed by the prescriber. Hands should be washed after application, and contact with eyes, mouth or open wounds should be avoided.

Although rare, serious adverse reactions can include severe contact dermatitis, skin ulceration, systemic hypersensitivity (rash, fever, angioedema) and photosensitivity. Patients should discontinue use and seek medical attention promptly if they experience intense itching, swelling, blistering, or any signs of an allergic reaction.

Individuals with a known hypersensitivity to ketoconazole, other azole antifungals, or any excipients in the formulation should avoid using the product. It is also contraindicated on extensive broken skin, mucous membranes, or in patients for whom a safer alternative is recommended by their clinician.